121 related articles for article (PubMed ID: 8265524)
1. Oral single doses of erythromycin and roxithromycin may increase the effects of midazolam on human performance.
Mattila MJ; Idänpään-Heikkilä JJ; Törnwall M; Vanakoski J
Pharmacol Toxicol; 1993 Sep; 73(3):180-5. PubMed ID: 8265524
[TBL] [Abstract][Full Text] [Related]
2. Grapefruit juice does not enhance the effects of midazolam and triazolam in man.
Vanakoski J; Mattila MJ; Seppälä T
Eur J Clin Pharmacol; 1996; 50(6):501-8. PubMed ID: 8858279
[TBL] [Abstract][Full Text] [Related]
3. 150 mg fluconazole does not substantially increase the effects of 10 mg midazolam or the plasma midazolam concentrations in healthy subjects.
Vanakoski J; Mattila MJ; Vainio P; Idänpään-Heikkilä JJ; Törnwall M
Int J Clin Pharmacol Ther; 1995 Sep; 33(9):518-23. PubMed ID: 8520811
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin does not alter the effects of oral midazolam on human performance.
Mattila MJ; Vanakoski J; Idänpään-Heikkilä JJ
Eur J Clin Pharmacol; 1994; 47(1):49-52. PubMed ID: 7988623
[TBL] [Abstract][Full Text] [Related]
5. Dose equivalence of midazolam and triazolam. A psychometric study based on flicker sensitivity, reaction time and digit symbol substitution test.
Sostmann HJ; Sostmann H; Crevoisier C; Bircher J
Eur J Clin Pharmacol; 1989; 36(2):181-7. PubMed ID: 2721543
[TBL] [Abstract][Full Text] [Related]
6. Midazolam 12 mg is moderately counteracted by 250 mg caffeine in man.
Mattila MJ; Vainio P; Nurminen ML; Vanakoski J; Seppälä T
Int J Clin Pharmacol Ther; 2000 Dec; 38(12):581-7. PubMed ID: 11125871
[TBL] [Abstract][Full Text] [Related]
7. A pharmacokinetic interaction between roxithromycin and midazolam.
Backman JT; Aranko K; Himberg JJ; Olkkola KT
Eur J Clin Pharmacol; 1994; 46(6):551-5. PubMed ID: 7995324
[TBL] [Abstract][Full Text] [Related]
8. A potentially hazardous interaction between erythromycin and midazolam.
Olkkola KT; Aranko K; Luurila H; Hiller A; Saarnivaara L; Himberg JJ; Neuvonen PJ
Clin Pharmacol Ther; 1993 Mar; 53(3):298-305. PubMed ID: 8453848
[TBL] [Abstract][Full Text] [Related]
9. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole.
Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
Clin Pharmacol Ther; 1997 Sep; 62(3):348-54. PubMed ID: 9333111
[TBL] [Abstract][Full Text] [Related]
10. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
Hallam KT; Olver JS; McGrath C; Norman TR
Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
[TBL] [Abstract][Full Text] [Related]
11. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol.
Kuitunen T; Mattila MJ; Seppala T
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():115-30. PubMed ID: 2201724
[TBL] [Abstract][Full Text] [Related]
12. Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam.
Zimmermann T; Yeates RA; Laufen H; Scharpf F; Leitold M; Wildfeuer A
Arzneimittelforschung; 1996 Feb; 46(2):213-7. PubMed ID: 8720318
[TBL] [Abstract][Full Text] [Related]
13. Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects.
Mattila ME; Mattila MJ; Nuotto E
Pharmacol Toxicol; 1992 Apr; 70(4):286-9. PubMed ID: 1351673
[TBL] [Abstract][Full Text] [Related]
14. Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose.
Borbély AA; Loepfe M; Mattmann P; Tobler I
Arzneimittelforschung; 1983; 33(10):1500-2. PubMed ID: 6140018
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies.
Greenblatt DJ; Harmatz JS; Gouthro TA; Locke J; Shader RI
Clin Pharmacol Ther; 1994 Jul; 56(1):100-11. PubMed ID: 8033487
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.
Berlin I; Warot D; Hergueta T; Molinier P; Bagot C; Puech AJ
J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity to triazolam in the elderly.
Greenblatt DJ; Harmatz JS; Shapiro L; Engelhardt N; Gouthro TA; Shader RI
N Engl J Med; 1991 Jun; 324(24):1691-8. PubMed ID: 2034245
[TBL] [Abstract][Full Text] [Related]
19. Single oral dose pharmacokinetics of erythromycin and roxithromycin and the effects of chronic dosing.
Birkett DJ; Robson RA; Grgurinovich N; Tonkin A
Ther Drug Monit; 1990 Jan; 12(1):65-71. PubMed ID: 2305423
[TBL] [Abstract][Full Text] [Related]
20. Lack of interaction of erythromycin with temazepam.
Luurila H; Olkkola KT; Neuvonen PJ
Ther Drug Monit; 1994 Dec; 16(6):548-51. PubMed ID: 7878692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
